山东中医药大学,济南 250355
梁书志,在读硕士,从事方剂效用机制及针药结合研究,E-mail:liang19861401632@163.com
张艳,博士,副教授,从事中药复方配伍及作用机制研究,E-mai:zhangyan@sdutcm.edu.cn
刘西建,博士,副教授,从事方剂效用机制及针药结合研究,E-mail:liuxijian@sdutcm.edu.cn; *
收稿:2025-04-18,
修回:2025-07-11,
录用:2025-07-23,
网络出版:2025-08-13,
纸质出版:2026-02-05
移动端阅览
梁书志,赵中敏,侯苏寓等.基于AGE/RAGE信号通路探讨半夏泻心汤改善血管性痴呆大鼠认知功能障碍的作用机制[J].中国实验方剂学杂志,2026,32(03):10-21.
LIANG Shuzhi,ZHAO Zhongmin,HOU Suyu,et al.Banxia Xiexin Tang Ameliorates Cognitive Dysfunction in Rat Model of Vascular Dementia via AGE/RAGE Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(03):10-21.
梁书志,赵中敏,侯苏寓等.基于AGE/RAGE信号通路探讨半夏泻心汤改善血管性痴呆大鼠认知功能障碍的作用机制[J].中国实验方剂学杂志,2026,32(03):10-21. DOI: 10.13422/j.cnki.syfjx.20251305.
LIANG Shuzhi,ZHAO Zhongmin,HOU Suyu,et al.Banxia Xiexin Tang Ameliorates Cognitive Dysfunction in Rat Model of Vascular Dementia via AGE/RAGE Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(03):10-21. DOI: 10.13422/j.cnki.syfjx.20251305.
目的
2
该研究旨在探讨半夏泻心汤(BXT)通过调控糖基化终产物/晚期糖基化终产物受体(AGE/RAGE)信号通路降低神经炎症反应,改善血管性痴呆(VD)大鼠认知功能障碍的作用机制。
方法
2
采用超高效液相色谱-四极杆-轨道阱串联质谱(UPLC-Q-Orbitrap-MS/MS)技术对BXT进行成分检测,运用网络药理学、分子对接技术筛选出核心成分与关键作用通路。60只SPF级SD雄性大鼠随机数字表法分为假手术组(Sham)、造模组,采用改良双侧颈总动脉结扎法(2-VO)复制VD模型,将造模成功的大鼠按照随机数字表法分为模型组(Model),半夏泻心汤低、中、高剂量组(BXT-L、BXT-M、BXT-H)和尼莫地平组(NMP),BXT-L、BXT-M、BXT-H分别给予BXT 3.748 5、7.497、14.994 g·kg
-1
,NMP给予NMP 0.002 7 g·kg
-1
,Sham、Model予等量生理盐水,连续14 d灌胃给药。Morris水迷宫、Y迷宫、新物体识别实验评估大鼠认知功能障碍。苏木素-伊红(HE)染色评估大鼠海马组织病理学变化。实时荧光定量聚合酶链式反应(Real-time PC
R)检测大鼠海马组织晚期AGE、RAGE、磷酸化核转录因子-
κ
B p65(p-NF-
κ
B p65)mRNA水平。蛋白免疫印迹法(Western blot)和免疫组化法(IHC)检测大鼠海马组织AGE/RAGE通信通路的相关蛋白表达。酶联免疫吸附测定法(ELISA)检测大鼠血清神经递质和炎症因子。
结果
2
UPLC-Q-Orbitrap-MS/MS技术检测BXT化学成分。网络药理学、分子对接技术筛选出AGE/RAGE信号通路作为关键通路。与Sham比较,Model大鼠成功潜伏期延长,穿越平台次数、自主交替率、进入新臂次数、偏好指数、辨别指数显著降低(
P
<
0.01);与Model比较,BXT-H、BXT-M大鼠成功潜伏期显著缩短(
P
<
0.01)、穿越平台次数、自主交替率、进入新臂次数、偏好指数、辨别指数明显增加(
P
<
0.05,
P
<
0.01)。HE结果显示,与Sham比较,Model大鼠细胞排列松散杂乱,细胞核固缩。与Model比较,BXT海马组织病理损伤明显改善。Real-time PCR结果显示,与Sham比较,Model大鼠海马组织AGE、RAGE、p-NF-
κ
B p65 mRNA显著升高(
P
<
0.01),与Model比较,BXT-H、BXT-M大鼠AGE、RAGE、p-NF-
κ
B p65 mRNA显著降低(
P
<
0.01),Western blot结果显示,与Sham比较,Model大鼠AGE、RAGE、p-NF-
κ
B p65、肿瘤坏死因子-
α
(TNF-
α
)表达明显增加(
P
<
0.05),与Model比较,BXT-H大鼠AGE、RAGE、p-NF-
κ
B p65、TNF-
α
表达明显降低(
P
<
0.05),IHC结果显示,与Sham比较,Model大鼠RAGE表达显著增加(
P
<
0.01),与Model比较,BXT-H、BXT-M大鼠RAGE表达显著降低(
P
<
0.01),ELISA结果显示,与Sham比较,Model大鼠血清TNF-
α
、白细胞介素-1
β
(IL-1
β
)水平显著升高,乙酰胆碱(ACh)和多巴胺(DA)水平显著降低(
P
<
0.01),与Model比较,BXT-L各剂量组大鼠血清TNF-
α
、IL-1
β
水平明显降低(
P
<
0.05),ACh和DA水平明显升高(
P
<
0.05)。
结论
2
BXT可能通过下调AGE/RAGE信号通路,减轻神经炎症反应,调节神经递质含量,从而改善VD认知功能障碍。
Objective
2
To explore the mechanism by which Banxia Xiexin Tang (BXT) regulates the advanced glycation end products (AGE)/receptor for advanced glycation end products (RAGE) signaling pathway to reduce neuroinflammatory responses and ameliorate cognitive dysfunction in the rat model of vascular dementia (VD).
Methods
2
The components of BXT were detect
ed by ultra performance liquid chromatography-quadrupole -orbitrap-tandem mass spectrometry(UPLC-Q-Orbitrap-MS/MS), and the core components and key action pathways were screened out by network pharmacology and molecular docking. Sixty SPF-grade male SD rats were randomly allocated into the sham and modeling groups by the random number table method. The VD model was replicated by the modified bilateral occlusion of the common carotid arteries (2-VO) method. The successfully modeled rats were randomly allocated into the model, low-, medium-, and high-dose (3.748 5, 7.497, 14.994 g·kg
-1
) BXT (BXT-L, BXT-M, and BXT-H), and nimodipine (NMP, 0.002 7 g·kg
-1
) groups according to the random number table method. The rats in the drug intervention groups were administrated with corresponding drugs by gavage, and the sham and model groups received the same amount of normal saline for 14 consecutive days. The Morris water maze, Y-maze, and new object recognition experiments were conducted to evaluate the cognitive dysfunction of rats. Hematoxylin-eosin (HE) staining was used to evaluate the histopathological changes of the hippocampal tissue in rats. The mRNA levels of AGE, RAGE, and phosphorylated nuclear factor-kappa B p65 (p-NF-
κ
B p65) in the hippocampal tissue of rats were determined by Real-time fluorescence quantitative polymerase chain reaction (Real-time PCR). The expression of related proteins in the AGE/RAGE pathway in the hippocampal tissue of rats was determined by Western blot and immunohistochemistry (IHC). The levels of neurotransmitters and inflammatory mediators in the rat serum were measured by enzyme-linked immunosorbent assay (ELISA).
Results
2
The chemical components of BXT were detected by UPLC-Q-Orbitrap-MS/MS. Network pharmacology and molecular docking identified the AGE/RAGE pathway as the key pathway. The results of the water maze, Y maze, and novel object recognition tests showed that compared with the sham group, the model group dem
onstrated prolonged successful latency and decreases in number of platform crossings, alternation rate, number of entries into the new arm, preference index, and discrimination index (
P
<
0.01). Compared with the model group, the BXT-H and BXT-M groups showed shortened successful latency (
P
<
0.01) and increases in number of platform crossings (
P
<
0.05), alternation rate (
P
<
0.01), number of entries into the new arm (
P
<
0.05), preference index (
P
<
0.01), and discrimination index (
P
<
0.01). HE results showed that compared with the sham group, the cells of model rats were loosely and disorderly arranged, and the nuclei were condensed. Compared with the model group, the pathological changes of the hippocampus in the BXT group were mitigated. Real-time PCR results showed that compared with the sham group, the model group presented up-regulated mRNA levels of AGE, RAGE, and p-NF-
κ
B p65 in the hippocampus (
P<
0.01), and compared with the model group, the BXT-H and BXT-M groups showcased down-regulated mRNA levels of AGE, RAGE, and p-NF-
κ
B p65 (
P<
0.01). Western blot results showed that compared with the sham group, the model group presented up-regulated expression of AGE, RAGE, p-NF-
κ
B p65, and tumor necrosis factor-
α
(TNF-
α
) (
P
<
0.05), and compared with the model group, the BXT-H group presented down-regulated expression of AGE, RAGE, p-NF-
κ
B p65, and TNF-
α
(
P
<
0.05). IHC results showed that compared with the sham group, the model group had increased expression of RAGE (
P
<
0.01), and compared with the model group, the BXT-H and BXT-M groups had reduced expression of RAGE (
P
<
0.01). ELISA results showed that compared with the sham group, the model group exhibite
d elevated levels of TNF-
α
and Interleukin-1
β
(IL-1
β
) and declined levels of acetylcholine (ACh) and dopamine (DA) in the serum (
P
<
0.01). Compared with the model group, the BXT-L, BXT-M, and BXT-H groups showed lowered levels of TNF-
α
and IL-1
β
in the serum (
P
<
0.05) and elevated levels of ACh and DA (
P
<
0.05).
Conclusion
2
BXT may ameliorate cognitive dysfunction in the rat model of VD by down-regulating the AGE/RAGE signaling pathway, reducing neuroinflammatory responses, and regulating neurotransmitter levels.
O'BRIEN J T , THOMAS A . Vascular dementia [J]. Lancet , 2015 , 386 ( 10004 ): 1698 - 1706 .
屈秋民 , 王瑾 , 曹红梅 . 认知障碍临床实践 [M]. 西安 : 陕西科学技术出版社 , 2024 : 451 .
QU Q M , WANG J , CAO H M . Clinical practice of cognitive impairment [M]. Xi'an : Shaanxi Science and Technology Press , 2024 : 451 .
VIJAYAN M , REDDY P H . Stroke,vascular dementia,and Alzheimer's disease:Molecular links [J]. J Alzheimers Dis , 2016 , 54 ( 2 ): 427 - 443 .
PRINCE M , BRYCE R , ALBANESE E . The global prevalence of dementia:A systematic review and metaanalysis [J]. Alzheimers Dement , 2013 , 9 ( 1 ): 63 - 75 .
卢靖 , 唐晓雷 , 杨兰 , 等 . 益脑复健方改善缺血性中风后神经损伤的作用机制 [J]. 中国医院药学杂志 , 2025 , 45 ( 10 ): 1094 - 1100 .
LU J , TANG X L , YANG L , et al . The mechanism of Yinao Fujian formula in improving nerve injury after ischemic stroke [J]. Chin J Hosp Pharm , 2025 , 45 ( 10 ): 1094 - 1100 .
赖泽飞 , 黄岚 . 中风一号方联合丁苯酞对急性脑梗死患者神经功能及血管内皮功能的影响 [J]. 江西中医药大学学报 , 2024 , 36 ( 6 ): 38 - 40,44 .
LAI Z F , HUANG L . Effects of stroke formula No.1 combined with butylphthalide on neurological function and vascular endothelial function in patients with acute cerebral infarction [J]. J Jiangxi Univ Chin Med , 2024 , 36 ( 6 ): 38 - 40,44 .
薛大力 , 张晓哲 , 王慧 , 等 . 通络益智方通过PERK介导的内质网应激途径减轻大鼠血管性痴呆模型记忆缺陷的实验研究 [J]. 现代检验医学杂志 , 2025 , 40 ( 1 ): 17 - 23 .
XVE D L , ZHANG X Z , WANG H , et al . Experimental study on the reduction of memory deficits in rat vascular dementia models by Tongluo Yizhi formula through PERK-mediated endoplasmic reticulum stress pathway [J]J . Mod Lab Med , 2025 , 40 ( 1 ): 17 - 23 .
王雪 , 张振勇 , 许彬 , 等 . 老年血管性痴呆病人血清VEGF、BDNF水平与病情严重程度的关系及对预后的预测价值 [J]. 实用老年医学 , 2025 , 39 ( 1 ): 32 - 36 .
WANG X , ZHANG Z Y , XV B , et al . The relationship between serum VEGF and BDNF levels and the severity of the disease in elderly patients with vascular dementia and their predictive value for prognosis [J]. Pract Geriat , 2025 , 39 ( 1 ): 32 - 36 .
周振龙 , 段禹 , 沙红玉 , 等 . 益气活血化瘀治法促进新血管生成治疗血管性痴呆的中医药研究进展 [J]. 中国实验方剂学杂志 , 2025 , doi: 10.13422/j.cnki.syfjx.20251221 http://dx.doi.org/10.13422/j.cnki.syfjx.20251221 .
ZHOU Z L , DUAN Y , SHA H Y , et al . Research progress of traditional Chinese medicine on promoting new blood vessel formation and treating vascular dementia by tonifying Qi,promoting blood circulation and removing blood stasis [J]. Chin J Exp Tradit Med Form , 2025 , doi: 10.13422/j.cnki.syfjx.20251221 http://dx.doi.org/10.13422/j.cnki.syfjx.20251221 .
GAO C Y , QIN G F , ZHENG M C , et al . Banxia Xiexin decoction alleviated cerebral glucose metabolism disorder by regulating intestinal microbiota in APP/PS1 mice [J]. Chin J Integr Med , 2024 , 30 ( 8 ): 701 - 712 .
SHI Y L , SHENG P , GUO M , et al . Banxia Xiexin decoction prevents HT22 cells from high glucose-induced neurotoxicity via JNK/SIRT1/FoxO3a signaling pathway [J]. Curr Comput Aided Drug Des , 2024 , 20 ( 6 ): 911 - 927 .
CHEN F , HE Y K , WANG P W . Banxia Xiexin decoction ameliorated cognition via the regulation of insulin pathways and glucose transporters in the hippocampus of APPswe/PS1dE9 mice [J]. Int J Immunopathol Pharmacol , 2018 , doi: 10.1177/2058738418780066 http://dx.doi.org/10.1177/2058738418780066 .
李振勇 , 张德全 . 温胆汤合半夏泻心汤治疗轻中度血管性痴呆临床观察 [J]. 山西中医 , 2024 , 40 ( 10 ): 23 - 25 .
LI Z Y , ZHANG D Q . Clinical observation on the treatment of mild to moderate vascular dementia with Wendan decoction combined with Banxia Xiexin decoction [J]. Shanxi J Chin Tradit Med , 2024 , 40 ( 10 ): 23 - 25 .
应春苗 , 潘小龙 , 王柏乔 , 等 . 中药抑制炎症反应干预血管性痴呆的研究进展 [J]. 中成药 , 2025 , 47 ( 1 ): 148 - 155 .
YING C M , PAN X L , WANG B Q , et al . Research progress on the inhibition of inflammatory response by traditional Chinese medicine in the intervention of vascular dementia [J]. Chin Tradit Pat Med , 2025 , 47 ( 1 ): 148 - 155 .
赵瑞国 , 刘海敬 , 陆依珊 , 等 . 电针联合干细胞移植治疗缺血性脑卒中的机制研究进展 [J]. 世界中医药 , 2025 , 20 ( 7 ): 1226 - 1232 .
ZHAO R G , LIU H J , LU Y S , et al . Research progress on the mechanism of electroacupuncture combined with stem cell transplantation in the treatment of ischemic stroke [J]. World J Tradit Chin Med , 2025 , 20 ( 7 ): 1226 - 1232 .
李姿 . 补肾填精类中药复方联合多奈哌齐治疗VaD的Meta分析及核心药物的网络药理学研究 [D]. 南宁 : 广西中医药大学 , 2024 .
LI Z . Meta-analysis of the combination of traditional Chinese medicine formulas for tonifying kidney and filling essence with donepezil in the treatment of vascular dementia and network pharmacology research on core drugs [D]. Nanning : Guangxi University of Chinese Medicine , 2024 .
KHALID M , PETROIANU G , ADEM A . Advanced glycation end products and diabetes mellitus:Mechanisms and perspectives [J]. Biomolecules , 2022 , 12 ( 4 ): 542 .
孙旭 , 王蕾 , 赵婧 , 等 . 血管性痴呆动物模型研究概述 [J]. 广州中医药大学学报 , 2022 , 39 ( 10 ): 2465 - 2470 .
SUN X,WANG L,ZHAO J,et al Research overview of animal models of vascular dementia [J]. J Guangzhou Univ Chin Med , 2022 , 39 ( 10 ): 2465 - 2470 .
WANG X J , ZHANG X X , LI J X . Network pharmacology and LC-MS approaches to explore the active compounds and mechanisms of Yuanjiang decoction for treating bradyarrhythmia [J]. Comput Biol Med , 2023 , 152 : 106435 .
黄楚瑶 , 魏桢文 , 郑宁香 , 等 . 当归芍药散通过调控cGAS-STING/IRF7/STAT3信号通路改善血管性痴呆的神经炎症 [J]. 中国实验方剂学杂志 , 2025 , 31 ( 17 ): 1 - 10 .
HUANG C Y , WEI Z W , ZHENG N X , et al . Danggui Shaoyao powder improves neuroinflammation in vascular dementia by regulating the cGAS-STING/IRF7/STAT3 signaling pathway [J]. Chin J Exp Tradit Med Form , 2025 , 31 ( 17 ): 1 - 10 .
祁桂芳 , 姜玥 , 谭韵湘 , 等 . 当归补血汤对血管性痴呆模型大鼠PINK1/Parkin通路的影响 [J]. 中国实验方剂学杂志 , 2025 , doi: 10.13422/j.cnki.syfjx.20251398 http://dx.doi.org/10.13422/j.cnki.syfjx.20251398 .
QI G F , JIANG Y , TAN Y X , et al . The effect of Danggui Buxue decoction on the PINK1/Parkin pathway in vascular dementia model rats [J]. Chin J Exp Tradit Med Form , 2025 , doi: 10.13422/j.cnki.syfjx.20251398 http://dx.doi.org/10.13422/j.cnki.syfjx.20251398 .
任天一 , 凌云 , 申一鸣 , 等 . 黄连及其方剂配伍防治糖尿病认知障碍研究进展 [J]. 中国实验方剂学杂志 , 2025 , 31 ( 20 ): 266 - 275 .
REN T Y , LING Y , SHEN Y M , et al . Research progress on the prevention and treatment of diabetic cognitive impairment with coptis chinensis and its formula combinations [J]. Chin J Exp Tradit Med Form , 2025 , 31 ( 20 ): 266 - 275 .
何雨洁 , 闫少珍 , 陈志庚 , 等 . 阿尔茨海默病患者基底前脑亚区功能连接变化模式 [J]. 中国医学影像技术 , 2025 , 41 ( 5 ): 701 - 705 .
HE Y J , YAN S Z , CHEN Z G , et al . Change patterns of functional connectivity in basal forebrain subregions of patients with Alzheimer's disease [J]. Chin J Med Imaging Technol , 2020 , 41 ( 5 ): 701 - 705 .
MATOUSEK S B , GHOSH S , SHAFTEL S S , et al . Chronic IL-1 β -mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration [J] J Neuroimmune Pharmacol , 2012 , 7 ( 1 ): 156 - 164 .
陈康智 . 抗帕金森病新型单胺氧化酶-B抑制剂的合成与活性研究 [D]. 广州 : 华南理工大学 , 2021 .
CHEN K Z . Synthesis and activity study of a novel monoamine oxidase-B inhibitor against Parkinson's disease [D]. Guangzhou : South China University of Technology , 2021 .
ZHANG Y , XU S Q , QIAN Y W , et al . Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota [J]. Front Aging Neurosci , 2023 , 15 : 1099018 .
白绿峰 , 李雅迪 , 朱垚羽 , 等 . 基于自噬探讨中药治疗帕金森病的研究进展 [J]. 中医学报 , 2025 , 40 ( 6 ): 1156 - 1162 .
BAI L F , LI Y D , ZHU Y Y , et al . Research progress on the treatment of Parkinson's disease with traditional Chinese medicine based on autophagy [J]. J Tradit Chin Med , 2025 , 40 ( 6 ): 1156 - 1162 .
贾璐璐 , 李颖 , 印加乐 , 等 . 中医药调控BDNF/TrkB通路治疗帕金森病的研究进展 [J]. 中国实验方剂学杂志 , 2025 , 31 ( 4 ): 315 - 322 .
JIA L L , LI Y , IN J L , et al . Research progress of traditional Chinese medicine regulating the BDNF/TrkB pathway in the treatment of Parkinson's disease [J]. Chin J Exp Tradit Med Form , 25 , 31 ( 4 ): 315 - 322 .
BLOEM B R , OKUN M S , KLEIN C . Parkinson's disease [J]. Lancet , 2021 , 397 ( 10291 ): 2284 - 2303 .
OTT T , NIEDER A . Dopamine and cognitive control in prefrontal cortex [J]. Trends Cogn Sci , 2019 , 23 ( 3 ): 213 - 234 .
POH L , SIM W L , JO D G , et al . The role of inflammasomes in vascular cognitive impairment [J]. Mol Neurodegener , 2022 , 17 ( 1 ): 4 .
MENG H L , ZHAO H R , CAO X , et al . Double-negative T cells remarkably promote neuroinflammation after ischemic stroke [J]. Proc Natl Acad Sci USA , 2019 , 116 ( 12 ): 5558 - 5563 .
ROCHFORT K D , COLLINS L E , MCLOUGHLIN A , et al . Tumour necrosis factor- α -mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the produ ction of proinflammatory interleukin-6 [J]. J Neurochem , 2016 , 136 ( 3 ): 564 - 572 .
RAJEEV V , FANN D Y , DINH Q N , et al . Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment [J]. Theranostics , 2022 , 12 ( 4 ): 1639 - 1658 .
VELLANKI S P , DULAPALLI R , KONDAGARI B , et al . Structural evaluation and binding mode analysis of CCL19 and CCR7 proteins:Identification of novel leads for rheumatic and autoimmune diseases:An insilico study [J]. Interdiscip Sci Comput Life Sci , 2018 , 10 ( 2 ): 346 - 366 .
REZAEI M , MARTINS CAVACO A C M , SEEBACH J , et al . Signals of the neuropilin-1-MET axis and cues of mechanical force rxertion converge to elicit inflammatory activation in coherent endothelial cells [J]. J Immunol , 2019 , 202 ( 5 ): 1559 - 1572 .
LEE K M , BANG J , KIM B Y , et al . Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling [J]. BMC Complementary Altern Med , 2015 , 15 ( 1 ): 125 .
YUAN B Q , SHI H , ZHENG K , et al . MCP-1-mediated activation of microglia promotes white matter lesions and cognitive deficits by chronic cerebral hypoperfusion in mice [J]. Mol Cell Neurosci . 2017 , 78 : 52 - 58 .
YE D S , MIYOSHI A , USHITANI T , et al . RAGE in circulating immune cells is fundamental for hippocampal inflammation and cognitive decline in a mouse model of latent chronic inflammation [J]. Brain Behav Immun . 2024 , 116 : 329 - 348 .
PRASAD K . AGE-RAGE stress:A changing landscape in pathology and treatment of Alzheimer's disease [J]. Mol Cell Biochem , 2019 , 459 ( 1-2 ): 95 - 112 .
WANG X , YU S , HU J P , et al . Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF- κ B pathway [J].. Int J Neurosci , 2014 , 124 ( 8 ): 601 - 608 .
GUGLIELMOTTO M , ARAGNO M , TAMAGNO E , et al . AGES/RAGE complex upregulates BACE1 via NF- κ B pathway activation [J]. Neurobiol Aging , 2012 , 33 ( 1 ): 196 .
BRINKLEY T E , SEMBA R D , KRITCHEVSKY S B , et al . Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the health,aging,and body composition study [J]. Am J Clin Nutr , 2020 , 112 ( 6 ): 1558 - 1565 .
KOPYTEK M , ZABCZYK M , MAZUR P , et al . Accumulation of advanced glycation end products(AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes [J]. Cardiovasc Diabetol , 2020 , 19 ( 1 ): 92 .
ADHIKARY L , CHOW F , NIKOLIC-PATERSON D J , et al . Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy [J]. Diabetologia , 2004 , 47 ( 7 ): 1210 - 1222 .
CHHIPA A S , BORSE S P , BAKSI R , et al . Targeting receptors of advanced glycation end products (RAGE):Preventing diabetes induced cancer and diabetic complications [J]. Pathol Res Pract , 2019 , 215 ( 11 ): 152643 .
0
浏览量
11
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
